JPS63160592A - Production of l-valine - Google Patents

Production of l-valine

Info

Publication number
JPS63160592A
JPS63160592A JP30732686A JP30732686A JPS63160592A JP S63160592 A JPS63160592 A JP S63160592A JP 30732686 A JP30732686 A JP 30732686A JP 30732686 A JP30732686 A JP 30732686A JP S63160592 A JPS63160592 A JP S63160592A
Authority
JP
Japan
Prior art keywords
valine
aminobutyric acid
alpha
culture medium
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP30732686A
Other languages
Japanese (ja)
Other versions
JPH0657155B2 (en
Inventor
Masato Terasawa
真人 寺沢
Yukie Sato
幸江 佐藤
Shoichi Nara
昭一 奈良
Hideaki Yugawa
英明 湯川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Petrochemical Co Ltd
Original Assignee
Mitsubishi Petrochemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Petrochemical Co Ltd filed Critical Mitsubishi Petrochemical Co Ltd
Priority to JP30732686A priority Critical patent/JPH0657155B2/en
Publication of JPS63160592A publication Critical patent/JPS63160592A/en
Publication of JPH0657155B2 publication Critical patent/JPH0657155B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:To efficiently obtain L-valine useful as a medicine, food or feed enriching agent by a fermentation method, by aerobically cultivating a microorganism, belonging to the genus Brevibacterium and having resistance to DL-alpha- aminobutyric acid in a nutrient culture medium. CONSTITUTION:Brevibacterium flavum MJ-233 (FERM-P No.3068) is subjected to ultraviolet light irradiation or chemical agent treatment to provide Brevibacterium flavum MJ-233-AB-41 (FERM-P No. 3812) having resistance to DL-alpha-aminobutyric acid. The resultant strain is the aerobically cultivated in a culture medium prepared by adding 0.1-5wt%, preferably 1-3wt% DL-alpha- aminobutyric acid to a culture medium containing 1-5vol%, preferably 2-3vol% carbon source, e.g. glucose, etc., as well as a nitrogen source, inorganic salt, if necessary, vitamin, etc., under aerobic condition at pH 5-10, preferably 7-8 and 20-40 deg.C, preferably 25-35 deg.C for 2-8 days, optimally 4-5 days to afford the aimed L-valine.

Description

【発明の詳細な説明】 技術分野 本発明は、L−バリンの製造法に関するものである。更
に詳しくは、プレピバクテリウム属に属しDL−α−ア
ミノ酪酸に耐性を有する微生物を好気的に培養して、そ
の培養液よりL−バリンを得る方法に関するものでろる
DETAILED DESCRIPTION OF THE INVENTION Technical Field The present invention relates to a method for producing L-valine. More specifically, it relates to a method of aerobically cultivating a microorganism belonging to the genus Prepibacterium and having resistance to DL-α-aminobutyric acid, and obtaining L-valine from the culture solution.

本発明の方法によれば、L−バリンの生成蓄積量が大巾
に向上し、高収量でL−バリンが製造できる。
According to the method of the present invention, the amount of L-valine produced and accumulated can be greatly improved, and L-valine can be produced in high yield.

L−バリンは必須アミノ酸として、人間及び動物の栄養
上重要な役割をするアミノ酸でアリ、医薬、食品、飼料
強化剤としての需要は近年急激に増加しつつある。
L-valine is an essential amino acid that plays an important role in the nutrition of humans and animals, and the demand for it as an ant, medicine, food, and feed fortifier has been rapidly increasing in recent years.

先行技術 L−バリンの工業的製造法としては、他のアミノ酸の場
合と同様に立体異性体が存在する為に化学合成法では、
L一体のみの製造は困難であるため、主として醗酵法に
よる生産が行なわれている。
Prior art As for the industrial production method of L-valine, chemical synthesis method is used because stereoisomers exist as in the case of other amino acids.
Since it is difficult to produce only one L, fermentation is mainly used to produce it.

従来、L−バリンの醗酵による製造法としては各積卸ら
れており、醗酵菌として栄養要求変異株を用いる方法(
特公昭37−1692、同37−12448、同42−
513、同43−11756、同51−33996、同
52−116、同53−25034、同58−3259
4、特開昭49−  ′116293各号公報等)、培
地に金属イオンを添加する方法(特公昭38−2528
4、同38−25286、同40−4040、同42−
513各号公報等)、プリン又はピリミジン誘導体を添
加する方法(特公昭40−1991号公報)、カルボン
酸エステルを添加する方法C特公昭43−11754号
公報)、バルビッール酸、2−チオバルビッール酸(特
公昭43−11755号公報)を添加する方法、界面活
性剤(特公昭41−21752号公報等)を添加する方
法、アクリル酸(特公昭43−13678号公報)を添
加する方法、有機酸(1!!!公昭47−23035、
同51−46836、特開昭49−50185各号公報
)を添加する方法等がある。
Conventionally, methods for manufacturing L-valine by fermentation have been carried out in various ways, including a method using an auxotrophic mutant strain as a fermentation bacterium (
Special Publications No. 37-1692, No. 37-12448, No. 42-
513, 43-11756, 51-33996, 52-116, 53-25034, 58-3259
4, JP-A-49-116293, etc.), a method of adding metal ions to the culture medium (Japanese Patent Publication No. 38-2528, etc.)
4, 38-25286, 40-4040, 42-
513 publications, etc.), the method of adding purine or pyrimidine derivatives (Japanese Patent Publication No. 40-1991), the method of adding carboxylic acid ester C (Japanese Patent Publication No. 11754-1975), barbylic acid, 2-thiobarbital acid (Japanese Patent Publication No. 43-11754), A method of adding a surfactant (Japanese Patent Publication No. 43-11755, etc.), a method of adding a surfactant (Japanese Patent Publication No. 41-21752, etc.), a method of adding acrylic acid (Japanese Patent Publication No. 43-13678), a method of adding an organic acid ( 1!!! Kosho 47-23035,
51-46836 and JP-A-49-50185).

しかしながら、公知のし一バリン直接醗酵菌である各種
栄養要求性変異株ではL−バリンの蓄積に限界があるこ
とから、新たな観点でL−バリンを著量生成蓄積せしめ
る方法の提供が求められていた。
However, since there is a limit to the accumulation of L-valine in various auxotrophic mutant strains that are known direct valine-fermenting bacteria, there is a need to provide a method for producing and accumulating significant amounts of L-valine from a new perspective. was.

発明の要旨 本発明は、プレピバクテリウム属に属し、DL−α−ア
ミノ酪酸に耐性を有する微生物を、栄養培地に好気的に
培養し培養液中にL−バリンを生成蓄積せしめ、この培
養液よりL−バリンを採取するものである、醗酵法によ
るL−バリンの製造法を提供するものである。
SUMMARY OF THE INVENTION The present invention involves aerobically cultivating a microorganism belonging to the genus Prepibacterium and having resistance to DL-α-aminobutyric acid in a nutrient medium to produce and accumulate L-valine in the culture solution. The present invention provides a method for producing L-valine by fermentation, in which L-valine is collected from a culture solution.

発明の効果 本発明の方法によれば、栄養培地中に従来になく著量の
L−バリンを生成蓄積できる。この為、L−バリンが安
価な原料で工業的に有利な収量高く製造することができ
る。
Effects of the Invention According to the method of the present invention, an unprecedented amount of L-valine can be produced and accumulated in a nutrient medium. For this reason, L-valine can be produced with an inexpensive raw material in a high yield which is industrially advantageous.

発明の詳細な説明 従来、α−アミノ酪酸耐性を有する変異株を用いての醗
酵法べよるL−バリンの製造法は、セラチア・マルセエ
センス(4?公昭+5−24274号公報)、プロテウ
ス・レトゲリ属菌株(特開昭59−143595号公報
)によるものがあるが、プレピバクテリウム属に属する
微生物についてはかかる知見は全く知られていない。
DETAILED DESCRIPTION OF THE INVENTION Conventionally, a method for producing L-valine based on a fermentation method using a mutant strain having α-aminobutyric acid resistance has been proposed using Serratia marsecens (4? Kosho +5-24274), Proteus letgeri spp. Although there is a method based on a bacterial strain (Japanese Unexamined Patent Publication No. 143595/1983), no such findings are known regarding microorganisms belonging to the genus Prepibacterium.

本発明において用いられるプレピバクテリウム属に属し
、DL−α−アミノ酪酸に耐性を有する微生物は、プレ
ピバクテリウムに属する微生物を次の操作により耐性変
異株とすることができる。
The microorganism belonging to the genus Prepibacterium used in the present invention and having resistance to DL-α-aminobutyric acid can be made into a resistant mutant strain by the following operation.

即ち、紫外線照射、めるいは化学的薬剤(例え1fN−
メfルーN/−ニトローN−ニトロソクアニジン等)処
理によ9該し−バリン生産菌株に変異を誘起せしめた後
、この菌懸濁液をα−アミノ酪酸101+9/117含
有する平板培地〔尿素0.2%、硫安0.7%、KH2
PO40,05%、KH2O40,05%、Mg5Oa
 ・7H200,05%、N1ン2 ”F / Lx 
Caαz・2HzO2’l/ t、 FeSO44?H
zO2’t/ LNMnSO4・4−6H20、ZnS
O4・7H202q/ L、ビオチン200μV/l、
チアミン塩酸塩100μV/!、、DL−α−アミノ酪
酸1.0%、寒天2.0%、エタノール2容量%(滅菌
後添加)〕に、30℃にて数日間培養し生じた大コロニ
ーを分離すること罠より、耐性変異株を得る。
That is, ultraviolet irradiation, chemical agents (such as 1fN-
After inducing mutations in the 9-valine producing bacterial strain by treatment (mef-N/-nitro-N-nitrosoquanidine, etc.), this bacterial suspension was transferred to a plate medium containing α-aminobutyric acid 101+9/117 [ Urea 0.2%, ammonium sulfate 0.7%, KH2
PO40.05%, KH2O40.05%, Mg5Oa
・7H200,05%, N1-2”F/Lx
Caαz・2HzO2'l/t, FeSO44? H
zO2't/ LNMnSO4・4-6H20, ZnS
O4・7H202q/L, biotin 200μV/L,
Thiamine hydrochloride 100μV/! , DL-α-aminobutyric acid 1.0%, agar 2.0%, ethanol 2% by volume (added after sterilization)] at 30°C for several days, and the resulting large colony was isolated. Obtain resistant mutants.

代表的な耐性変異株としてはプレピバクテリウム・フラ
バムMJ−233−AB−41(微工研菌寄第3812
号、特公昭59−28398号参照。以下MJ−233
−AB−41と記す)があり、この耐性変異株は、ブレ
ビバクテリタム・フラバムMJ−233(微工研菌寄第
3068号、以下MJ−233と記す)から上記手法で
誘導されたものである。
A typical resistant mutant strain is Prepibacterium flavum MJ-233-AB-41 (Feikoken Bacterium 3812
No., Special Publication No. 59-28398. Below MJ-233
-AB-41), and this resistant mutant strain was derived from Brevibacterium flavum MJ-233 (Feikoken Bacterium No. 3068, hereinafter referred to as MJ-233) using the above method. be.

前記のMJ−233−AB−41(DL−α−アミノ酪
酸耐性株)とその親株であるM J −233のα−ア
ミノ酪酸に対する相対生育度は次の表−1のり口くであ
る。
The relative growth rates of MJ-233-AB-41 (DL-α-aminobutyric acid resistant strain) and its parent strain M J-233 against α-aminobutyric acid are shown in Table 1 below.

表−1 注)表中の数値は、DL−α−アミノ酪酸無添加時の生
育度0.D、ato (吸光度測定二東京大学農学部農
芸化学教室実験農芸化学上巻p。
Table 1 Note: The values in the table are the growth rate 0.0% without the addition of DL-α-aminobutyric acid. D, ato (Absorbance measurement 2 Department of Agricultural Chemistry, Faculty of Agriculture, University of Tokyo, Volume 1, p.

212朝倉書店、1978年に準拠して行った)をio
oとした相対生育度を示す。
212 Asakura Shoten, 1978)
The relative growth rate is shown as o.

注)使用培地の組成及び培養方法 尿素0.2%、髄安0.7%、KH2PO40,05%
、K2HPO40,05%、MgSO4・7H200,
05%、酵母エキス0.01%、カザミノ酸0.01%
、FeSO4・7Hz02 Wt / L、  Mn5
O4a 4−’6HzO2q/ z、 NaCJ 2 
’9/ L、 Ca(Jz、2H202N!/ L、 
 ZnSO4・7H202yy/ t。
Note) Composition of the medium used and culture method Urea 0.2%, ammonium 0.7%, KH2PO 40.05%
, K2HPO40.05%, MgSO4・7H200,
05%, yeast extract 0.01%, casamino acid 0.01%
, FeSO4・7Hz02 Wt/L, Mn5
O4a 4-'6HzO2q/z, NaCJ 2
'9/ L, Ca (Jz, 2H202N!/ L,
ZnSO4・7H202yy/t.

ビオチン200μy/l、チアミン塩酸塩100μy/
lからなる培地(DL−α−アミノ酪酸は、表−1に示
す量をそれぞれ加える)10xiを24g3大型試験管
に分注し、120℃で10分間滅菌後、MJ−233−
AB−41株及びMJ−233株を各々接種し、更にエ
タノールを無菌条件下にて0.2Kt(2容量%)添加
したものを30℃で3日間振盪培養を行なった。
Biotin 200μy/l, thiamine hydrochloride 100μy/l
Dispense 10 x 1 of a medium consisting of 1 ml (DL-α-aminobutyric acid is added in the amount shown in Table 1) into 24 g3 large test tubes, and after sterilizing at 120°C for 10 minutes, MJ-233-
AB-41 strain and MJ-233 strain were each inoculated, and 0.2 Kt (2% by volume) of ethanol was added under aseptic conditions, followed by shaking culture at 30° C. for 3 days.

なお本願発明においてDL−α−アミノ酪酸耐性株又は
DL−α−アミノ酪酸に耐性を有する微生物とは、DL
−α−アミノ酪酸2%添加した上記培地において、30
℃で3日間振盪培養した時の、 α−AB2%添加時の生育度0.D 610相対生育度
w               X 100α−AB
無添力時の生育度0.Or+。
In addition, in the present invention, the DL-α-aminobutyric acid resistant strain or the microorganism resistant to DL-α-aminobutyric acid refers to DL
- In the above medium supplemented with 2% α-aminobutyric acid, 30
When cultured with shaking at ℃ for 3 days, the growth rate when 2% α-AB was added was 0. D 610 relative growth w X 100α-AB
Growth rate without additives: 0. Or+.

が30以上のものと定義する。(上式中のα−ABはD
L−α−アミノ酪酸の略号である。)本発明のL−バリ
ン製造法における培養に使用する培地組成は、炭素源及
び窒素源無機塩は特に限定されない。通常、炭素源とし
ては主にグルコースを用い、窒素源としてはアンモニア
、硫酸アンモニウム、塩化アンモニウム、硝酸アンモニ
ウム、尿素を単独もしくは混合し用いることができる。
is defined as 30 or more. (α-AB in the above formula is D
It is an abbreviation for L-α-aminobutyric acid. ) The composition of the medium used for culture in the L-valine production method of the present invention is not particularly limited in terms of carbon source and nitrogen source inorganic salts. Generally, glucose is mainly used as the carbon source, and ammonia, ammonium sulfate, ammonium chloride, ammonium nitrate, and urea can be used alone or in combination as the nitrogen source.

無機塩としては、リン酸−水素カリウム、リン酸二水素
カリウム、硫酸マグネシウム等が用いられる。この他に
菌の生育及びL−バリンの生育に必要であれば、ぺ1ト
ン、肉エキス、酵母エキス、コーンステイープリカー、
カザミノ酸、各押ビタミン等の栄養素を培地に添加し用
いることができる。
As the inorganic salt, potassium hydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate, etc. are used. In addition, if necessary for the growth of bacteria and L-valine, Pelton, meat extract, yeast extract, cornstarch liquor, etc.
Nutrients such as casamino acids and various pressed vitamins can be added to the culture medium.

培養は通気攪拌、振盪等の好気的条件下で行ない、培!
!!温度は20〜40℃、好ましくは25〜35℃で行
なう。培養途中のpHは5〜10、好ましくは7〜8付
近にて行ない、培養液中のpHの調整には酸、アルカリ
を添加して行なう。DL−α−アミノ酪酸の添加濃度は
、0.1〜5重量%好ましくけ、1〜3重箭%である。
Culture is performed under aerobic conditions such as aeration, stirring, and shaking.
! ! The temperature is 20-40°C, preferably 25-35°C. The pH during the cultivation is maintained at around 5 to 10, preferably around 7 to 8, and the pH in the culture solution is adjusted by adding acid or alkali. The concentration of DL-α-aminobutyric acid added is preferably 0.1 to 5% by weight, and 1 to 3% by weight.

培養開始時のグルコース濃度は1〜5容t%、好ましく
は2〜3容量%が適する。培養期間は2〜8日、最適期
間は4〜5日である。
A suitable glucose concentration at the start of culture is 1 to 5 t% by volume, preferably 2 to 3 t% by volume. The culture period is 2-8 days, the optimal period is 4-5 days.

培養液からのL−バリンの回収は、培養液を遠心分離に
より、菌体の除去後、公知の手法、すなわちイオン交換
樹脂処理法あるいは、沈殿法等により容易に行なうこと
ができる。
Recovery of L-valine from the culture solution can be easily carried out by centrifuging the culture solution to remove bacterial cells, and then using a known method such as an ion exchange resin treatment method or a precipitation method.

実験例 以下の実験例においてL−バリンの定性は、ペーパーク
ロマトグラムのRf値、電気泳動法の易動度、微生物に
よる生物活性値により確認した。
Experimental Examples In the following experimental examples, the quality of L-valine was confirmed by the Rf value of paper chromatogram, the mobility of electrophoresis, and the biological activity value by microorganisms.

定欧は、ロイコノストック・メセンテロイデスATC,
C8042を用いるマイクロバイオアッセイ法により行
なった。またシと表したのは重量%を意味する。
The fixed Europe is Leuconostoc mesenteroides ATC,
The test was carried out using a microbioassay method using C8042. Moreover, the expression "shi" means weight %.

実施例−1 前培養培地(尿素0.4%、硫酸アンモニウム1.4%
、K2HPO40,05%、KHzPOa 0.05%
、Mg5Oae7Hzo 0.05%、CaC2z 会
2H202ppm %FeSO4・7H202ppmS
MnSO4・4−6H20229m%Zn5Oi・7H
202ppmN  Na(J 2 ppm、  ビオチ
ン200μy/l、チアミン・)ICtl 00μ?/
11 カザミノ酸0.1%、酵母エキス0.1%)10
dを24β大型試験管に分注、滅菌(滅菌後pH7,0
)した。これに更に別滅菌(120℃、15分間)を行
って調製した50%グルコース溶液0.2 mを加えた
後、更にプレピバクテリウム・フラバム(Brevib
acterium Flavum ) M J −23
3−A B −41(FERM P−3812)を植菌
し、30℃にてpHを7〜7.5に調節しつつ2日間振
盪培養を行なった。
Example-1 Preculture medium (urea 0.4%, ammonium sulfate 1.4%
, K2HPO40.05%, KHzPOa 0.05%
, Mg5Oae7Hzo 0.05%, CaC2z 2H202ppm %FeSO4・7H202ppmS
MnSO4・4-6H20229m%Zn5Oi・7H
202ppmN Na (J2ppm, biotin 200μy/l, thiamin.) ICtl 00μ? /
11 Casamino acids 0.1%, yeast extract 0.1%) 10
Dispense d into 24β large test tubes and sterilize (pH 7.0 after sterilization)
)did. After adding 0.2 ml of a 50% glucose solution prepared by further sterilization (120°C, 15 minutes), Prepibacterium flavum (Brevib
acterium Flavum) MJ-23
3-A B-41 (FERM P-3812) was inoculated and cultured with shaking at 30° C. for 2 days while adjusting the pH to 7 to 7.5.

次に本培傳培地(尿素0.4%、硫酸アンモニウム1.
4%、KH2PO40,05%、K2HPO40,05
%、MgSO4・7H200,05%、CaC1z @
 2H202m” %FeSO417HsO2ppmS
MnSO4・4−6I(202ppm。
Next, use this culture medium (urea 0.4%, ammonium sulfate 1.
4%, KH2PO40.05%, K2HPO40.05
%, MgSO4・7H200,05%, CaC1z @
2H202m” %FeSO417HsO2ppmS
MnSO4.4-6I (202 ppm.

ZnSO4・7H202ppm、 NaCt2 ppm
、  ビオチン200 fit/l、チアミン” Hc
tl 00 pf/Z% コーンステイープリカー10
d/1)50−を500d三角フラスコに分注、滅菌し
た(滅菌後pH7)。
ZnSO4・7H202ppm, NaCt2ppm
, Biotin 200 fit/l, Thiamine” Hc
tl 00 pf/Z% corn staple liquor 10
d/1) 50- was dispensed into a 500d Erlenmeyer flask and sterilized (pH 7 after sterilization).

これにさらに別滅菌(120℃、15分間)した50%
グルコース溶液2dを添加後、前培養物の1 mlを植
菌し、30℃にて3日間pHを7〜7.5に調節しつつ
振盪培養を行なった。培養3日目にL−バリンが培養液
1を当92.Of蓄積された。
50% of this was further sterilized (120℃, 15 minutes)
After adding 2 d of glucose solution, 1 ml of the preculture was inoculated and cultured with shaking at 30° C. for 3 days while adjusting the pH to 7 to 7.5. On the third day of culture, L-valine added culture solution 1 to 92. Of accumulated.

培養液から菌体その他不純物を除いたF液を、強酸性陽
イオン交換樹脂(H+型)のカラムに通してL−バリン
を吸着させ、水洗後、0.5規定アンモニア水で溶出し
たのち、L−バリン画分を濃縮し、冷エタノールでL−
バリンの結晶を析出させた。かくして培養液1を当り1
.3fの粗結晶を得た。
Solution F, which has been removed from the culture solution by bacterial cells and other impurities, is passed through a column of strongly acidic cation exchange resin (H+ type) to adsorb L-valine, washed with water, and eluted with 0.5N ammonia water. Concentrate the L-valine fraction and add L-valine to cold ethanol.
Crystals of valine were precipitated. Thus, 1 culture solution per 1
.. A crude crystal of 3f was obtained.

なお、同条件で親株であるMJ−233を使用した場合
、培地中のL−バリンの蓄積は培養液1を当り50叩以
下であった。
Note that when the parent strain MJ-233 was used under the same conditions, the accumulation of L-valine in the medium was 50 or less per 1 culture solution.

Claims (1)

【特許請求の範囲】[Claims] (1)プレピバクテリウム属に属し、DL−α−アミノ
酪酸に耐性を有する微生物を、栄養培地に好気的に培養
し培養液中にL−バリンを生成蓄積せしめ、この培養液
よりL−バリンを採取するものである、醗酵法によるL
−バリンの製造法。
(1) A microorganism belonging to the genus Prepibacterium and resistant to DL-α-aminobutyric acid is cultured aerobically in a nutrient medium, L-valine is produced and accumulated in the culture solution, and L-valine is produced and accumulated in the culture solution. -L by fermentation method, which is to collect valine
- Method for producing valine.
JP30732686A 1986-12-23 1986-12-23 Method for producing L-valine Expired - Lifetime JPH0657155B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP30732686A JPH0657155B2 (en) 1986-12-23 1986-12-23 Method for producing L-valine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30732686A JPH0657155B2 (en) 1986-12-23 1986-12-23 Method for producing L-valine

Publications (2)

Publication Number Publication Date
JPS63160592A true JPS63160592A (en) 1988-07-04
JPH0657155B2 JPH0657155B2 (en) 1994-08-03

Family

ID=17967791

Family Applications (1)

Application Number Title Priority Date Filing Date
JP30732686A Expired - Lifetime JPH0657155B2 (en) 1986-12-23 1986-12-23 Method for producing L-valine

Country Status (1)

Country Link
JP (1) JPH0657155B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477000A2 (en) * 1990-09-18 1992-03-25 Kyowa Hakko Kogyo Co., Ltd. Process for producing L-valine
CN102517239A (en) * 2011-08-16 2012-06-27 Cj第一制糖株式会社 A microorganism having enhanced L-valine productivity and process for preparing L-valine using the same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477000A2 (en) * 1990-09-18 1992-03-25 Kyowa Hakko Kogyo Co., Ltd. Process for producing L-valine
CN102517239A (en) * 2011-08-16 2012-06-27 Cj第一制糖株式会社 A microorganism having enhanced L-valine productivity and process for preparing L-valine using the same
EP2559753A1 (en) 2011-08-16 2013-02-20 CJ CheilJedang Corporation Microorganism having enhanced L-valine productivity and method for producing L-valine using the same
DE102011088151A1 (en) 2011-08-16 2013-02-21 Cj Cheil Jedang Corp. Microorganism with increased L-valine productivity and method for producing L-valine using the same
US8465962B2 (en) 2011-08-16 2013-06-18 Cj Cheiljedang Corporation Microorganism having enhanced L-valine productivity and method for producing L-valine using the same

Also Published As

Publication number Publication date
JPH0657155B2 (en) 1994-08-03

Similar Documents

Publication Publication Date Title
JPS6274293A (en) Production of l-isoleucine
US5188947A (en) Process and microorganism for producing l-ornithine by corynebacterium, brevibacterium, or athrobacter
JPH0632626B2 (en) Fermentation method for producing L-threonine
US3734829A (en) Fermentative preparation of l-arginine
JPS63160592A (en) Production of l-valine
JPS61119194A (en) Production of l-ornithine through fermentation process
JP3100763B2 (en) Method for producing L-arginine by fermentation
US2947666A (en) Amino acids and process
JPS61177993A (en) Production of l-isoleucine
JP2995816B2 (en) Production method of L-lysine by fermentation method
US3661711A (en) Method of producing l-histidinol by fermentation
JPS6078593A (en) Preparation of adenosine by fermentation
JPS6224075B2 (en)
JP2830378B2 (en) Production method of adenosine by fermentation method
JP3289349B2 (en) Method for producing D-alanine by fermentation method
JPS62265988A (en) Production of l-arginine by fermentation
JPH0242995A (en) Production of l-lysine
JPS6251998A (en) Production of l-isoleucine
JP2582806B2 (en) Method for producing L-isoleucine
JPS63267285A (en) Production of l-valine
JPH02295491A (en) Preparation of l-isoleucine
JPS5928398B2 (en) Method for producing L-isoleucine
JPH0313874B2 (en)
JPH01120296A (en) Production of l-isoleucine
JPS6244193A (en) Production of l-threonine by fermentation